IL10 and neoplasm: In models of breast cancer, cutaneous squamous cell carcinoma, and lymphoma, IL-10 deficiency correlates with increased tumor burden and impaired immune surveillance, along with elevated rates of CD8+ T cell exhaustion (67, 68).